| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.81 | 0.003 | 0.81 | 5 Hydroxytryptamine release stimulant | 0.724 0.005 CID_154699781 | ||
| 0.746 | 0.005 | 0.746 | Aldehyde oxidase inhibitor | |||
| 0.756 | 0.017 | 0.756 | Caspase 9 stimulant | 0.731 0.02 CID_154699781 | ||
| 0.735 | 0.002 | 0.735 | Tyrosine 3 hydroxylase inhibitor | 0.207 0.123 CID_154699781 | ||
| 0.724 | 0.004 | 0.807 | 5 Hydroxytryptamine release inhibitor | 0.807 0.003 CID_154699781 | CID_154699781 | |
| 0.642 | 0.007 | 0.758 | Histamine release inhibitor | 0.758 0.004 CID_154699781 | CID_154699781 | |
| 0.612 | 0.017 | 0.774 | Cholesterol antagonist | 0.774 0.005 CID_154699781 | CID_154699781 | |
| 0.601 | 0.007 | 0.601 | GABA C receptor rho-3 antagonist | |||
| 0.586 | 0.005 | 0.586 | Peroxidase inhibitor | |||
| 0.558 | 0.003 | 0.57 | Neurotrophic factor enhancer | 0.57 0.003 CID_154699781 | CID_154699781 | |
| 0.55 | 0.003 | 0.55 | Alcohol oxidase inhibitor | 0.061 0.035 CID_154699781 | ||
| 0.548 | 0.014 | 0.548 | Calcium channel L-type activator | 0.313 0.146 CID_154699781 | ||
| 0.537 | 0.004 | 0.537 | 5 Hydroxytryptamine uptake stimulant | 0.258 0.073 CID_154699781 | ||
| 0.536 | 0.01 | 0.536 | Superoxide dismutase inhibitor | |||
| 0.53 | 0.006 | 0.53 | Anesthetic general | 0.512 0.007 CID_154699781 | ||
| 0.495 | 0.041 | 0.495 | 15-Lipoxygenase inhibitor | |||
| 0.483 | 0.047 | 0.775 | Transcription factor NF kappa B inhibitor | 0.775 0.015 CID_154699781 | CID_154699781 | |
| 0.434 | 0.01 | 0.621 | Melanin inhibitor | 0.621 0.004 CID_154699781 | CID_154699781 | |
| 0.448 | 0.024 | 0.672 | Vasodilator, coronary | 0.672 0.005 CID_154699781 | CID_154699781 | |
| 0.46 | 0.037 | 0.46 | Vasodilator, peripheral | 0.44 0.043 CID_154699781 | ||
| 0.429 | 0.009 | 0.429 | Phospholipase C inhibitor | 0.338 0.015 CID_154699781 | ||
| 0.422 | 0.003 | 0.422 | Ferrochelatase inhibitor | 0.124 0.051 CID_154699781 | ||
| 0.446 | 0.027 | 0.446 | Lipoxygenase inhibitor | |||
| 0.443 | 0.03 | 0.443 | 12-Lipoxygenase inhibitor | |||
| 0.41 | 0.004 | 0.41 | Porphobilinogen synthase inhibitor | |||
| 0.404 | 0.005 | 0.404 | Aldehyde dehydrogenase inhibitor | 0.349 0.008 CID_154699781 | ||
| 0.419 | 0.032 | 0.678 | Antioxidant | 0.678 0.007 CID_154699781 | CID_154699781 | |
| 0.404 | 0.023 | 0.404 | Calcium channel activator | |||
| 0.392 | 0.019 | 0.392 | Sodium/bile acid cotransporter inhibitor | 0.315 0.066 CID_154699781 | ||
| 0.392 | 0.02 | 0.55 | Interleukin agonist | 0.55 0.006 CID_154699781 | CID_154699781 | |
| 0.4 | 0.029 | 0.61 | Free radical scavenger | 0.61 0.008 CID_154699781 | CID_154699781 | |
| 0.422 | 0.055 | 0.568 | Immunosuppressant | 0.568 0.017 CID_154699781 | CID_154699781 | |
| 0.369 | 0.004 | 0.369 | Estrogen receptor beta antagonist | |||
| 0.406 | 0.048 | 0.801 | Antithrombotic | 0.801 0.004 CID_154699781 | CID_154699781 | |
| 0.364 | 0.006 | 0.364 | Cystathionine beta-synthase inhibitor | 0.308 0.009 CID_154699781 | ||
| 0.367 | 0.011 | 0.594 | Alpha-N-acetylglucosaminidase inhibitor | 0.594 0.004 CID_154699781 | CID_154699781 | |
| 0.358 | 0.003 | 0.358 | Creatine kinase inhibitor | 0.085 0.079 CID_154699781 | ||
| 0.359 | 0.005 | 0.359 | Estrogen antagonist | 0.11 0.075 CID_154699781 | ||
| 0.385 | 0.032 | 0.495 | Interleukin 2 agonist | 0.495 0.009 CID_154699781 | CID_154699781 | |
| 0.365 | 0.013 | 0.66 | Monophenol monooxygenase inhibitor | 0.66 0.004 CID_154699781 | CID_154699781 | |
| 0.366 | 0.034 | 0.728 | Hypoglycemic | 0.728 0.005 CID_154699781 | CID_154699781 | |
| 0.335 | 0.004 | 0.335 | TRPA1 agonist | 0.184 0.014 CID_154699781 | ||
| 0.376 | 0.045 | 0.5 | Spasmolytic | 0.5 0.023 CID_154699781 | CID_154699781 | |
| 0.355 | 0.024 | 0.509 | Cyclic AMP phosphodiesterase inhibitor | 0.509 0.006 CID_154699781 | CID_154699781 | |
| 0.333 | 0.004 | 0.333 | Phenylalanine 4-hydroxylase inhibitor | |||
| 0.359 | 0.03 | 0.369 | Psychostimulant | 0.369 0.028 CID_154699781 | CID_154699781 | |
| 0.349 | 0.024 | 0.349 | RNA-directed DNA polymerase inhibitor | 0.274 0.038 CID_154699781 | ||
| 0.356 | 0.032 | 0.356 | Insulysin inhibitor | |||
| 0.345 | 0.024 | 0.345 | Growth hormone agonist | |||
| 0.343 | 0.031 | 0.343 | Sigma receptor agonist | |||
| 0.401 | 0.09 | 0.838 | Cyclophilin D inhibitor | 0.838 0.005 CID_154699781 | CID_154699781 | |
| 0.318 | 0.008 | 0.318 | Succinate dehydrogenase inhibitor | 0.178 0.07 CID_154699781 | ||
| 0.379 | 0.072 | 0.379 | Calpain 2 inhibitor | |||
| 0.311 | 0.01 | 0.311 | Cholesterol synthesis inhibitor | 0.241 0.019 CID_154699781 | ||
| 0.302 | 0.003 | 0.302 | Prolactin inhibitor | |||
| 0.309 | 0.014 | 0.309 | Insulin sensitizer | 0.304 0.015 CID_154699781 | ||
| 0.299 | 0.005 | 0.299 | Alcohol dehydrogenase inhibitor | 0.229 0.009 CID_154699781 | ||
| 0.303 | 0.009 | 0.303 | GABA C receptor agonist | |||
| 0.305 | 0.019 | 0.481 | Interferon gamma antagonist | 0.481 0.007 CID_154699781 | CID_154699781 | |
| 0.298 | 0.014 | 0.298 | Phospholipase A2 inhibitor | 0.264 0.02 CID_154699781 | ||
| 0.325 | 0.042 | 0.428 | Hypolipemic | 0.428 0.02 CID_154699781 | CID_154699781 | |
| 0.302 | 0.023 | 0.302 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.225 0.055 CID_154699781 | ||
| 0.276 | 0.003 | 0.276 | DOPA decarboxylase inhibitor | 0.108 0.061 CID_154699781 | ||
| 0.291 | 0.02 | 0.379 | Lipid peroxidase inhibitor | 0.379 0.011 CID_154699781 | CID_154699781 | |
| 0.272 | 0.005 | 0.406 | Photosensitizer | 0.406 0.003 CID_154699781 | CID_154699781 | |
| 0.283 | 0.016 | 0.283 | Nitric-oxide synthase stimulant | 0.281 0.017 CID_154699781 | ||
| 0.281 | 0.019 | 0.463 | Protein kinase stimulant | 0.463 0.005 CID_154699781 | CID_154699781 | |
| 0.327 | 0.068 | 0.542 | Apoptosis antagonist | 0.542 0.015 CID_154699781 | CID_154699781 | |
| 0.267 | 0.01 | 0.267 | Carbonic anhydrase XV inhibitor | |||
| 0.268 | 0.014 | 0.268 | 5-Lipoxygenase inhibitor | |||
| 0.255 | 0.005 | 0.255 | Vanilloid 1 agonist | 0.224 0.008 CID_154699781 | ||
| 0.298 | 0.049 | 0.429 | Vasodilator | 0.429 0.019 CID_154699781 | CID_154699781 | |
| 0.255 | 0.006 | 0.255 | Estrogen agonist | 0.086 0.021 CID_154699781 | ||
| 0.322 | 0.073 | 0.58 | Immunostimulant | 0.58 0.019 CID_154699781 | CID_154699781 | |
| 0.272 | 0.023 | 0.585 | Amylase inhibitor | 0.585 0.004 CID_154699781 | CID_154699781 | |
| 0.253 | 0.006 | 0.253 | Estrogen receptor alpha antagonist | |||
| 0.255 | 0.009 | 0.255 | Carbonic anhydrase III inhibitor | 0.14 0.033 CID_154699781 | ||
| 0.278 | 0.032 | 0.278 | Neuropeptide Y2 antagonist | |||
| 0.246 | 0.002 | 0.246 | Dopamine D5 agonist | |||
| 0.251 | 0.006 | 0.251 | CF transmembrane conductance regulator agonist | 0.188 0.029 CID_154699781 | ||
| 0.25 | 0.009 | 0.25 | Toll-Like receptor 2 antagonist | 0.12 0.077 CID_154699781 | ||
| 0.254 | 0.013 | 0.254 | Interleukin 4 antagonist | 0.186 0.027 CID_154699781 | ||
| 0.247 | 0.006 | 0.247 | Arachidonic acid antagonist | 0.206 0.028 CID_154699781 | ||
| 0.298 | 0.057 | 0.298 | Transcription factor STAT inhibitor | |||
| 0.344 | 0.106 | 0.664 | Antibacterial | 0.664 0.012 CID_154699781 | CID_154699781 | |
| 0.248 | 0.012 | 0.248 | GABA C receptor rho-2 antagonist | |||
| 0.27 | 0.035 | 0.545 | Non-steroidal antiinflammatory agent | 0.545 0.005 CID_154699781 | CID_154699781 | |
| 0.242 | 0.007 | 0.242 | GABA C receptor antagonist | |||
| 0.245 | 0.01 | 0.343 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.343 0.005 CID_154699781 | CID_154699781 | |
| 0.242 | 0.009 | 0.242 | Histidine decarboxylase inhibitor | |||
| 0.236 | 0.004 | 0.236 | Sphingosine 1-phosphate receptor 5 antagonist | |||
| 0.27 | 0.038 | 0.434 | Peptidyltransferase inhibitor | 0.434 0.005 CID_154699781 | CID_154699781 | |
| 0.28 | 0.049 | 0.28 | Gastrin inhibitor | 0.244 0.087 CID_154699781 | ||
| 0.289 | 0.059 | 0.289 | Transcription factor STAT3 inhibitor | |||
| 0.234 | 0.005 | 0.234 | Adenylate cyclase stimulant | 0.171 0.035 CID_154699781 | ||
| 0.244 | 0.018 | 0.244 | DNA polymerase I inhibitor | 0.222 0.022 CID_154699781 | ||
| 0.275 | 0.049 | 0.275 | 5 Hydroxytryptamine 1E antagonist | |||
| 0.246 | 0.022 | 0.246 | Neurotensin receptor agonist | |||
| 0.233 | 0.014 | 0.432 | UDP-glucose 4-epimerase inhibitor | 0.432 0.004 CID_154699781 | CID_154699781 | |
| 0.268 | 0.049 | 0.268 | Calpain inhibitor | |||
| 0.359 | 0.141 | 0.359 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | |||
| 0.224 | 0.007 | 0.224 | HIV-1 integrase (Overall Integration) inhibitor | |||
| 0.222 | 0.006 | 0.222 | Sphingosine 1-phosphate receptor 4 antagonist | |||
| 0.268 | 0.052 | 0.268 | Amyloid beta aggregation inhibitor | 0.151 0.107 CID_154699781 | ||
| 0.221 | 0.005 | 0.221 | Glutamate decarboxylase inhibitor | |||
| 0.22 | 0.005 | 0.22 | Sphingosine 1-phosphate receptor 2 antagonist | |||
| 0.352 | 0.137 | 0.605 | Apoptosis agonist | 0.605 0.048 CID_154699781 | CID_154699781 | |
| 0.269 | 0.056 | 0.429 | DNA synthesis inhibitor | 0.429 0.019 CID_154699781 | CID_154699781 | |
| 0.271 | 0.061 | 0.798 | Angiogenesis stimulant | 0.798 0.004 CID_154699781 | CID_154699781 | |
| 0.214 | 0.004 | 0.214 | Estrogen receptor alpha agonist | |||
| 0.216 | 0.014 | 0.582 | Cyclooxygenase 3 inhibitor | 0.582 0.002 CID_154699781 | CID_154699781 | |
| 0.279 | 0.077 | 0.313 | Hypoxia-inducible factor 1 alpha inhibitor | 0.313 0.06 CID_154699781 | CID_154699781 | |
| 0.219 | 0.017 | 0.219 | Aminopeptidase B inhibitor | |||
| 0.218 | 0.02 | 0.218 | Neurotrophic factor | 0.165 0.047 CID_154699781 | ||
| 0.199 | 0.003 | 0.199 | Estrogen-related receptor beta agonist | |||
| 0.223 | 0.028 | 0.223 | NADPH oxidase inhibitor | 0.152 0.053 CID_154699781 | ||
| 0.203 | 0.008 | 0.203 | Keratolytic | |||
| 0.283 | 0.088 | 0.332 | Caspase 3 stimulant | 0.332 0.065 CID_154699781 | CID_154699781 | |
| 0.223 | 0.03 | 0.223 | Bone formation stimulant | 0.151 0.058 CID_154699781 | ||
| 0.253 | 0.06 | 0.253 | Interleukin antagonist | |||
| 0.235 | 0.045 | 0.235 | Dual specificity phosphatase 3 inhibitor | |||
| 0.193 | 0.005 | 0.193 | Estrogen receptor beta agonist | 0.041 0.021 CID_154699781 | ||
| 0.189 | 0.004 | 0.189 | Ca2+-transporting ATPase inhibitor | 0.184 0.005 CID_154699781 | ||
| 0.192 | 0.009 | 0.192 | GABA C receptor rho-1 antagonist | |||
| 0.203 | 0.022 | 0.203 | Cathepsin H inhibitor | |||
| 0.211 | 0.031 | 0.211 | Nav1.2 sodium channel blocker | |||
| 0.235 | 0.056 | 0.476 | Nitric oxide antagonist | 0.476 0.018 CID_154699781 | CID_154699781 | |
| 0.186 | 0.008 | 0.186 | Adrenaline agonist | |||
| 0.213 | 0.036 | 0.361 | NOS3 expression enhancer | 0.361 0.01 CID_154699781 | CID_154699781 | |
| 0.191 | 0.015 | 0.198 | Carbonic anhydrase XIII inhibitor | 0.198 0.014 CID_154699781 | CID_154699781 | |
| 0.28 | 0.104 | 0.28 | Thyroid hormone antagonist | |||
| 0.185 | 0.01 | 0.185 | Electron transport complex I inhibitor | 0.11 0.062 CID_154699781 | ||
| 0.193 | 0.02 | 0.193 | Falcipain 3 inhibitor | |||
| 0.187 | 0.015 | 0.187 | Carbonic anhydrase VI inhibitor | 0.08 0.057 CID_154699781 | ||
| 0.181 | 0.009 | 0.181 | Macrophage migration inhibitory factor inhibitor | |||
| 0.245 | 0.073 | 0.341 | Antiamyloidogenic | 0.341 0.041 CID_154699781 | CID_154699781 | |
| 0.184 | 0.013 | 0.383 | Triose-phosphate isomerase inhibitor | 0.383 0.004 CID_154699781 | CID_154699781 | |
| 0.186 | 0.017 | 0.515 | Mediator release inhibitor | 0.515 0.004 CID_154699781 | CID_154699781 | |
| 0.177 | 0.008 | 0.177 | Anabolic | 0.124 0.036 CID_154699781 | ||
| 0.177 | 0.008 | 0.177 | Vanilloid agonist | 0.091 0.046 CID_154699781 | ||
| 0.192 | 0.024 | 0.192 | Farnesoid X receptor antagonist | |||
| 0.17 | 0.004 | 0.17 | Nicotinic acid receptor agonist | |||
| 0.175 | 0.009 | 0.175 | Peroxisome proliferator-activated receptor gamma agonist | 0.112 0.023 CID_154699781 | ||
| 0.2 | 0.035 | 0.363 | Hexokinase inhibitor | 0.363 0.005 CID_154699781 | CID_154699781 | |
| 0.213 | 0.049 | 0.213 | Dual specificity phosphatase inhibitor | |||
| 0.169 | 0.004 | 0.169 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | |||
| 0.342 | 0.179 | 0.795 | Antiinflammatory | 0.795 0.016 CID_154699781 | CID_154699781 | |
| 0.191 | 0.028 | 0.191 | Proteasome inhibitor | |||
| 0.169 | 0.007 | 0.169 | Ornithine decarboxylase inhibitor | 0.14 0.014 CID_154699781 | ||
| 0.171 | 0.009 | 0.171 | Aminopeptidase I inhibitor | 0.065 0.06 CID_154699781 | ||
| 0.177 | 0.015 | 0.177 | Sphingomyelinase inhibitor | 0.164 0.019 CID_154699781 | ||
| 0.164 | 0.004 | 0.164 | GABA B receptor agonist | |||
| 0.163 | 0.004 | 0.163 | Sphingosine kinase 2 inhibitor | |||
| 0.173 | 0.014 | 0.299 | Phosphofructokinase-1 inhibitor | 0.299 0.005 CID_154699781 | CID_154699781 | |
| 0.192 | 0.034 | 0.192 | Anesthetic local | |||
| 0.176 | 0.019 | 0.176 | Adenylate kinase inhibitor | 0.142 0.03 CID_154699781 | ||
| 0.199 | 0.043 | 0.199 | Acetylcholine M1 receptor antagonist | |||
| 0.172 | 0.016 | 0.178 | Heat shock protein 70 antagonist | 0.178 0.013 CID_154699781 | CID_154699781 | |
| 0.162 | 0.006 | 0.162 | Purinergic P2X1 antagonist | 0.094 0.018 CID_154699781 | ||
| 0.162 | 0.006 | 0.162 | GABA aminotransferase inhibitor | 0.144 0.009 CID_154699781 | ||
| 0.213 | 0.057 | 0.213 | P-glycoprotein inhibitor | 0.205 0.061 CID_154699781 | ||
| 0.178 | 0.023 | 0.178 | Bronchodilator | |||
| 0.163 | 0.008 | 0.163 | Lanosterol 14 alpha demethylase inhibitor | |||
| 0.169 | 0.014 | 0.169 | ABCA1 expression enhancer | |||
| 0.159 | 0.004 | 0.159 | Peroxisome proliferator-activated receptor delta antagonist | 0.038 0.017 CID_154699781 | ||
| 0.195 | 0.041 | 0.195 | Thiol protease inhibitor | |||
| 0.161 | 0.008 | 0.161 | Leukotriene synthesis inhibitor | |||
| 0.157 | 0.004 | 0.157 | Enoyl-[acyl-carrier-protein] reductase inhibitor | |||
| 0.172 | 0.019 | 0.172 | NMDA receptor antagonist | |||
| 0.156 | 0.004 | 0.156 | Sphingosine kinase inhibitor | |||
| 0.17 | 0.021 | 0.17 | Catalase inhibitor | |||
| 0.236 | 0.089 | 0.265 | DNA damaging | 0.265 0.073 CID_154699781 | CID_154699781 | |
| 0.203 | 0.058 | 0.203 | 5 Hydroxytryptamine 3E antagonist | |||
| 0.155 | 0.01 | 0.155 | Leukotriene antagonist | 0.144 0.011 CID_154699781 | ||
| 0.159 | 0.015 | 0.159 | NMDA 2 receptor antagonist | |||
| 0.15 | 0.007 | 0.15 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.149 0.007 CID_154699781 | ||
| 0.167 | 0.024 | 0.177 | Mucolytic | 0.177 0.02 CID_154699781 | CID_154699781 | |
| 0.193 | 0.05 | 0.193 | Protein-tyrosine phosphatase inhibitor | 0.177 0.058 CID_154699781 | ||
| 0.235 | 0.093 | 0.235 | Cardiotonic | |||
| 0.15 | 0.008 | 0.15 | Sphingosine 1-phosphate receptor 4 agonist | |||
| 0.152 | 0.013 | 0.152 | Histamine N-methyltransferase inhibitor | |||
| 0.145 | 0.007 | 0.145 | NMDA receptor subunit 3B antagonist | |||
| 0.146 | 0.008 | 0.146 | Bile acid receptor antagonist | 0.106 0.038 CID_154699781 | ||
| 0.142 | 0.004 | 0.142 | CC chemokine 5 receptor agonist | |||
| 0.166 | 0.03 | 0.166 | Pregnane X receptor agonist | |||
| 0.16 | 0.023 | 0.16 | Opioid antagonist | |||
| 0.192 | 0.055 | 0.192 | Antipruritic | |||
| 0.252 | 0.117 | 0.252 | Thyroid hormone beta antagonist | |||
| 0.21 | 0.075 | 0.21 | Pyruvate kinase inhibitor | |||
| 0.143 | 0.01 | 0.143 | Biliverdin reductase inhibitor | 0.099 0.019 CID_154699781 | ||
| 0.159 | 0.026 | 0.159 | Papain-like protease (SARS coronavirus) inhibitor | |||
| 0.169 | 0.036 | 0.169 | Nav1.6 sodium channel blocker | |||
| 0.149 | 0.018 | 0.287 | NADH dehydrogenase inhibitor | 0.287 0.007 CID_154699781 | CID_154699781 | |
| 0.143 | 0.012 | 0.223 | Phosphodiesterase 6D inhibitor | 0.223 0.004 CID_154699781 | CID_154699781 | |
| 0.147 | 0.017 | 0.147 | CYP2A6 inhibitor | |||
| 0.151 | 0.022 | 0.151 | Transcription factor STAT6 inhibitor | |||
| 0.138 | 0.009 | 0.138 | Glycine receptor agonist | 0.12 0.013 CID_154699781 | ||
| 0.2 | 0.071 | 0.467 | Platelet adhesion inhibitor | 0.467 0.007 CID_154699781 | CID_154699781 | |
| 0.183 | 0.054 | 0.31 | ATPase inhibitor | 0.31 0.005 CID_154699781 | CID_154699781 | |
| 0.136 | 0.007 | 0.136 | Beta 3 adrenoreceptor antagonist | |||
| 0.146 | 0.019 | 0.155 | Acetylcholine release stimulant | 0.155 0.014 CID_154699781 | CID_154699781 | |
| 0.13 | 0.004 | 0.13 | Glutamate (mGluR7) antagonist | |||
| 0.156 | 0.03 | 0.156 | Interleukin 8 antagonist | |||
| 0.203 | 0.077 | 0.32 | DNA methylase inhibitor | 0.32 0.023 CID_154699781 | CID_154699781 | |
| 0.138 | 0.013 | 0.138 | Myeloperoxidase inhibitor | |||
| 0.179 | 0.055 | 0.277 | Interleukin 6 antagonist | 0.277 0.018 CID_154699781 | CID_154699781 | |
| 0.132 | 0.008 | 0.132 | NMDA 2A receptor antagonist | |||
| 0.128 | 0.005 | 0.128 | Sphingosine 1-phosphate receptor 3 antagonist | |||
| 0.133 | 0.009 | 0.133 | Granulocyte macrophage colony stimulating factor agonist | |||
| 0.161 | 0.038 | 0.161 | MAO A inhibitor | |||
| 0.126 | 0.007 | 0.198 | Leukotriene B4 antagonist | 0.198 0.004 CID_154699781 | CID_154699781 | |
| 0.133 | 0.013 | 0.133 | Argininosuccinate synthase inhibitor | 0.092 0.021 CID_154699781 | ||
| 0.128 | 0.009 | 0.128 | Beta adrenoreceptor antagonist | |||
| 0.195 | 0.076 | 0.195 | Histone acetyltransferase inhibitor | |||
| 0.141 | 0.022 | 0.141 | NAD(P)H dehydrogenase (quinone) inhibitor | |||
| 0.152 | 0.034 | 0.237 | Xanthine oxidase inhibitor | 0.237 0.014 CID_154699781 | CID_154699781 | |
| 0.14 | 0.022 | 0.14 | Opioid delta receptor antagonist | |||
| 0.14 | 0.022 | 0.14 | Interleukin 1 beta converting enzyme inhibitor | |||
| 0.175 | 0.059 | 0.175 | Catenin beta inhibitor | |||
| 0.174 | 0.058 | 0.374 | Diuretic | 0.374 0.014 CID_154699781 | CID_154699781 | |
| 0.151 | 0.035 | 0.445 | Expectorant | 0.445 0.004 CID_154699781 | CID_154699781 | |
| 0.13 | 0.014 | 0.183 | Glycine receptor antagonist | 0.183 0.004 CID_154699781 | CID_154699781 | |
| 0.21 | 0.095 | 0.416 | Platelet antagonist | 0.416 0.024 CID_154699781 | CID_154699781 | |
| 0.126 | 0.012 | 0.126 | Carbonic anhydrase VB inhibitor | |||
| 0.129 | 0.015 | 0.129 | Lipase inhibitor | 0.085 0.038 CID_154699781 | ||
| 0.135 | 0.021 | 0.135 | Opioid mu receptor antagonist | |||
| 0.132 | 0.02 | 0.132 | Opioid kappa receptor antagonist | |||
| 0.136 | 0.023 | 0.136 | Cathepsin G inhibitor | |||
| 0.118 | 0.006 | 0.118 | Beta 2 adrenoreceptor antagonist | |||
| 0.169 | 0.057 | 0.36 | Insulin secretagoues | 0.36 0.008 CID_154699781 | CID_154699781 | |
| 0.116 | 0.005 | 0.116 | Liver X receptor alpha agonist | |||
| 0.139 | 0.028 | 0.188 | Toll-Like receptor 4 antagonist | 0.188 0.008 CID_154699781 | CID_154699781 | |
| 0.186 | 0.075 | 0.507 | Hepatoprotectant | 0.507 0.007 CID_154699781 | CID_154699781 | |
| 0.28 | 0.17 | 0.539 | Alpha-glucosidase inhibitor | 0.539 0.069 CID_154699781 | CID_154699781 | |
| 0.153 | 0.043 | 0.153 | Adenylate cyclase inhibitor | |||
| 0.158 | 0.048 | 0.158 | M18 aspartyl aminopeptidase inhibitor | |||
| 0.163 | 0.053 | 0.339 | Cell wall synthesis inhibitor | 0.339 0.008 CID_154699781 | CID_154699781 | |
| 0.125 | 0.015 | 0.187 | Interferon agonist | 0.187 0.007 CID_154699781 | CID_154699781 | |
| 0.154 | 0.044 | 0.171 | Protein-tyrosine phosphatase 1B inhibitor | 0.171 0.038 CID_154699781 | CID_154699781 | |
| 0.129 | 0.02 | 0.129 | Glutamate dehydrogenase inhibitor | 0.091 0.036 CID_154699781 | ||
| 0.116 | 0.008 | 0.116 | Beta 1 adrenoreceptor antagonist | |||
| 0.185 | 0.077 | 0.294 | DNA methyltransferase I inhibitor | 0.294 0.028 CID_154699781 | CID_154699781 | |
| 0.115 | 0.007 | 0.115 | NMDA receptor subunit 3A antagonist | |||
| 0.121 | 0.013 | 0.121 | D-Ala-D-Ala ligase inhibitor | |||
| 0.134 | 0.027 | 0.134 | Electrolyte absorption antagonist | |||
| 0.134 | 0.027 | 0.134 | Androgen antagonist | |||
| 0.208 | 0.102 | 0.485 | Tumour necrosis factor alpha release inhibitor | 0.485 0.015 CID_154699781 | CID_154699781 | |
| 0.135 | 0.03 | 0.135 | Nitric-oxide synthase inhibitor | |||
| 0.109 | 0.004 | 0.109 | Sphingosine kinase 1 inhibitor | |||
| 0.158 | 0.054 | 0.158 | Neuropeptide Y1 antagonist | |||
| 0.172 | 0.068 | 0.172 | Heat shock protein 90 alpha antagonist | |||
| 0.124 | 0.02 | 0.124 | Carbonic anhydrase V inhibitor | |||
| 0.142 | 0.039 | 0.142 | Chelator | |||
| 0.159 | 0.056 | 0.159 | MAO inhibitor | |||
| 0.123 | 0.021 | 0.123 | Analgesic, opioid | |||
| 0.115 | 0.013 | 0.115 | Acyl-CoA dehydrogenase inhibitor | 0.061 0.033 CID_154699781 | ||
| 0.143 | 0.042 | 0.194 | Microtubule formation inhibitor | 0.194 0.021 CID_154699781 | CID_154699781 | |
| 0.124 | 0.023 | 0.124 | Inducible nitric-oxide synthase inhibitor | |||
| 0.138 | 0.038 | 0.138 | Caspase 3 inhibitor | |||
| 0.138 | 0.038 | 0.138 | Nav1.1 sodium channel blocker | |||
| 0.156 | 0.056 | 0.162 | Alkaline phosphatase inhibitor | 0.162 0.053 CID_154699781 | CID_154699781 | |
| 0.114 | 0.015 | 0.114 | Sphingosine 1-phosphate receptor antagonist | |||
| 0.103 | 0.003 | 0.103 | ATP citrate lysase inhibitor | 0.029 0.026 CID_154699781 | ||
| 0.102 | 0.003 | 0.102 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | |||
| 0.169 | 0.07 | 0.169 | Death-associated protein kinase 2 inhibitor | |||
| 0.161 | 0.064 | 0.161 | Heat shock protein 90 antagonist | |||
| 0.12 | 0.024 | 0.12 | Interleukin 5 antagonist | 0.107 0.034 CID_154699781 | ||
| 0.1 | 0.004 | 0.1 | Glutamate (mGluR3) antagonist | 0.033 0.031 CID_154699781 | ||
| 0.1 | 0.004 | 0.1 | Dopamine beta hydroxylase inhibitor | |||
| 0.119 | 0.023 | 0.119 | Glutathione S-transferase inhibitor | |||
| 0.115 | 0.019 | 0.115 | Carbonic anhydrase VA inhibitor | |||
| 0.107 | 0.012 | 0.107 | Glycine transporter 2 inhibitor | |||
| 0.131 | 0.035 | 0.131 | Urease inhibitor | |||
| 0.099 | 0.004 | 0.099 | Leukotriene C antagonist | 0.062 0.025 CID_154699781 | ||
| 0.104 | 0.01 | 0.104 | MAP kinase kinase 7 inhibitor | |||
| 0.109 | 0.017 | 0.109 | Prostaglandin EP2 antagonist | 0.104 0.018 CID_154699781 | ||
| 0.117 | 0.024 | 0.126 | Glutamate release inhibitor | 0.126 0.018 CID_154699781 | CID_154699781 | |
| 0.112 | 0.019 | 0.112 | Aromatase inhibitor | |||
| 0.105 | 0.013 | 0.105 | Androgen agonist | |||
| 0.096 | 0.005 | 0.096 | Beta 2 adrenoreceptor agonist | |||
| 0.103 | 0.011 | 0.135 | Interferon inducer | 0.135 0.005 CID_154699781 | CID_154699781 | |
| 0.096 | 0.005 | 0.096 | Vanilloid 2 antagonist | |||
| 0.103 | 0.014 | 0.103 | Peroxisome proliferator-activated receptor gamma antagonist | 0.068 0.058 CID_154699781 | ||
| 0.103 | 0.015 | 0.103 | NMDA 2C receptor antagonist | |||
| 0.111 | 0.023 | 0.111 | Nicotinic alpha4beta2 receptor antagonist | |||
| 0.099 | 0.011 | 0.099 | Glutamate (mGluR6) antagonist | 0.069 0.043 CID_154699781 | ||
| 0.1 | 0.012 | 0.1 | Peroxisome proliferator-activated receptor alpha agonist | 0.066 0.024 CID_154699781 | ||
| 0.103 | 0.015 | 0.103 | Maillard reaction inhibitor | 0.051 0.042 CID_154699781 | ||
| 0.153 | 0.065 | 0.47 | Hemostatic | 0.47 0.005 CID_154699781 | CID_154699781 | |
| 0.092 | 0.005 | 0.092 | Liver X receptor beta agonist | |||
| 0.227 | 0.14 | 0.227 | Prostaglandin dehydrogenase inhibitor | |||
| 0.094 | 0.008 | 0.094 | Epithelial sodium channel blocker | 0.055 0.038 CID_154699781 | ||
| 0.092 | 0.006 | 0.092 | Nicotinic acid receptor 2 agonist | |||
| 0.09 | 0.004 | 0.09 | Pregnane X receptor antagonist | |||
| 0.15 | 0.065 | 0.163 | Mannose-6-phosphate isomerase inhibitor | 0.163 0.054 CID_154699781 | CID_154699781 | |
| 0.138 | 0.053 | 0.269 | Alkylator | 0.269 0.015 CID_154699781 | CID_154699781 | |
| 0.131 | 0.047 | 0.131 | 5 Hydroxytryptamine 3A agonist | |||
| 0.094 | 0.01 | 0.094 | Sphingosine 1-phosphate receptor 1 antagonist | |||
| 0.125 | 0.041 | 0.323 | Beta glucuronidase inhibitor | 0.323 0.005 CID_154699781 | CID_154699781 | |
| 0.107 | 0.024 | 0.107 | CDC25A inhibitor | |||
| 0.103 | 0.02 | 0.103 | Carbamoyl phosphate synthetase inhibitor | 0.058 0.045 CID_154699781 | ||
| 0.126 | 0.044 | 0.383 | AMP-activated protein kinase stimulant | 0.383 0.004 CID_154699781 | CID_154699781 | |
| 0.087 | 0.005 | 0.087 | Estradiol 17 beta-dehydrogenase 3 inhibitor | |||
| 0.12 | 0.038 | 0.12 | Antineoplastic alkaloid | |||
| 0.092 | 0.009 | 0.092 | Nicotinic alpha3beta2 receptor antagonist | |||
| 0.121 | 0.039 | 0.121 | Breast cancer-resistant protein inhibitor | |||
| 0.139 | 0.057 | 0.139 | Antibacterial (Helicobacter pylori) | |||
| 0.136 | 0.054 | 0.136 | Acetylcholine muscarinic antagonist | |||
| 0.086 | 0.004 | 0.086 | Geranyltranstransferase inhibitor | |||
| 0.086 | 0.005 | 0.086 | Immunoglobulin Fc receptor antagonist | |||
| 0.122 | 0.041 | 0.122 | Gastric antisecretory | |||
| 0.166 | 0.085 | 0.166 | Lipocortins synthesis antagonist | 0.158 0.094 CID_154699781 | ||
| 0.106 | 0.026 | 0.126 | Na+ K+ transporting ATPase inhibitor | 0.126 0.013 CID_154699781 | CID_154699781 | |
| 0.188 | 0.108 | 0.188 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | |||
| 0.101 | 0.022 | 0.101 | Ca(v)3.1 blocker | |||
| 0.09 | 0.012 | 0.09 | Estradiol 17 beta-dehydrogenase inhibitor | |||
| 0.164 | 0.086 | 0.164 | Amyloid beta precursor protein antagonist | |||
| 0.113 | 0.036 | 0.148 | Thioredoxin inhibitor | 0.148 0.017 CID_154699781 | CID_154699781 | |
| 0.082 | 0.004 | 0.082 | Liver X receptor beta antagonist | |||
| 0.085 | 0.008 | 0.085 | Lysophosphatidic acid 3 receptor antagonist | |||
| 0.088 | 0.011 | 0.088 | Oleamide hydrolase inhibitor | |||
| 0.128 | 0.052 | 0.128 | Alpha 2b adrenoreceptor antagonist | |||
| 0.086 | 0.012 | 0.086 | Aconitate hydratase inhibitor | |||
| 0.094 | 0.019 | 0.094 | TRPA1 antagonist | |||
| 0.085 | 0.011 | 0.085 | Potassium channel Kv1.3 blocker | |||
| 0.095 | 0.021 | 0.095 | Vanilloid 4 agonist | |||
| 0.086 | 0.013 | 0.086 | Glucosylceramidase inhibitor | 0.058 0.033 CID_154699781 | ||
| 0.157 | 0.084 | 0.157 | Mcl-1 antagonist | |||
| 0.08 | 0.007 | 0.08 | Leukotriene D4 antagonist | 0.023 0.021 CID_154699781 | ||
| 0.081 | 0.008 | 0.081 | Adenylate cyclase 1 inhibitor | |||
| 0.082 | 0.01 | 0.082 | Liver X receptor agonist | |||
| 0.081 | 0.009 | 0.081 | Adenosine deaminase inhibitor | 0.078 0.01 CID_154699781 | ||
| 0.088 | 0.016 | 0.088 | Heat shock protein 90 beta antagonist | |||
| 0.108 | 0.036 | 0.108 | Phosphodiesterase I inhibitor | |||
| 0.091 | 0.02 | 0.091 | Protease 3C (Human rhinovirus) inhibitor | |||
| 0.152 | 0.08 | 0.378 | Thrombolytic | 0.378 0.013 CID_154699781 | CID_154699781 | |
| 0.082 | 0.01 | 0.249 | Alpha-mannosidase inhibitor | 0.249 0.003 CID_154699781 | CID_154699781 | |
| 0.08 | 0.01 | 0.08 | Squalene epoxidase inhibitor | |||
| 0.091 | 0.02 | 0.091 | CDC25B inhibitor | |||
| 0.088 | 0.018 | 0.088 | Cannabinoid CB2 receptor antagonist | |||
| 0.092 | 0.021 | 0.092 | Carbonic anhydrase stimulant | |||
| 0.094 | 0.024 | 0.105 | Phosphodiesterase VI inhibitor | 0.105 0.017 CID_154699781 | CID_154699781 | |
| 0.11 | 0.04 | 0.131 | Interleukin 12 antagonist | 0.131 0.021 CID_154699781 | CID_154699781 | |
| 0.144 | 0.074 | 0.144 | MAP kinase kinase 4 inhibitor | |||
| 0.095 | 0.027 | 0.095 | Dopamine D1 antagonist | |||
| 0.096 | 0.027 | 0.096 | Amidase inhibitor | |||
| 0.077 | 0.008 | 0.077 | Retinoid X receptor agonist | |||
| 0.089 | 0.021 | 0.089 | Potassium channel (ATP-sensitive) blocker | |||
| 0.113 | 0.045 | 0.113 | Potassium channel (Ca-activated) activator | |||
| 0.07 | 0.002 | 0.118 | Vanilloid 2 agonist | 0.118 0.001 CID_154699781 | CID_154699781 | |
| 0.072 | 0.004 | 0.072 | Leukotriene C4 antagonist | 0.041 0.022 CID_154699781 | ||
| 0.077 | 0.009 | 0.266 | Mannosidase inhibitor | 0.266 0.002 CID_154699781 | CID_154699781 | |
| 0.076 | 0.008 | 0.076 | Cholesterol esterase inhibitor | 0.046 0.036 CID_154699781 | ||
| 0.119 | 0.053 | 0.119 | Nav1.4 sodium channel blocker | |||
| 0.076 | 0.01 | 0.115 | Glucose-6-phosphate isomerase inhibitor | 0.115 0.004 CID_154699781 | CID_154699781 | |
| 0.073 | 0.007 | 0.073 | Prostaglandin agonist | 0.031 0.021 CID_154699781 | ||
| 0.12 | 0.055 | 0.12 | Sphingosine 1-phosphate receptor 2 agonist | |||
| 0.199 | 0.134 | 0.199 | Streptokinase A inhibitor | |||
| 0.082 | 0.018 | 0.082 | Fatty acid synthase inhibitor | |||
| 0.067 | 0.004 | 0.067 | Thyroid hormone agonist | |||
| 0.076 | 0.012 | 0.076 | Ryanodine receptor antagonist | |||
| 0.08 | 0.017 | 0.116 | Carbonic anhydrase XIV inhibitor | 0.116 0.008 CID_154699781 | CID_154699781 | |
| 0.129 | 0.066 | 0.129 | Cholinergic antagonist | |||
| 0.085 | 0.023 | 0.085 | Ribonucleoside-diphosphate reductase inhibitor | |||
| 0.106 | 0.044 | 0.106 | Calcium antagonist | |||
| 0.085 | 0.023 | 0.085 | 5 Hydroxytryptamine 2A agonist | |||
| 0.086 | 0.024 | 0.086 | Ribonucleotide reductase inhibitor | |||
| 0.067 | 0.006 | 0.067 | Beta adrenoreceptor agonist | |||
| 0.065 | 0.004 | 0.223 | Sodium/glucose cotransporter inhibitor | 0.223 0.001 CID_154699781 | CID_154699781 | |
| 0.179 | 0.118 | 0.179 | ErbB-1 antagonist | |||
| 0.069 | 0.009 | 0.069 | Sphingosine 1-phosphate receptor 1 agonist | |||
| 0.08 | 0.019 | 0.08 | Phosphodiesterase 1C inhibitor | |||
| 0.063 | 0.002 | 0.063 | Nicotinic acid receptor 1 antagonist | |||
| 0.071 | 0.011 | 0.071 | Sphingosine 1-phosphate receptor agonist | |||
| 0.069 | 0.009 | 0.069 | Dihydropteroate synthase inhibitor | |||
| 0.065 | 0.005 | 0.15 | Sodium/glucose cotransporter 2 inhibitor | 0.15 0.001 CID_154699781 | CID_154699781 | |
| 0.063 | 0.003 | 0.063 | Nicotinic acid receptor 2 antagonist | |||
| 0.068 | 0.008 | 0.1 | Cytokine production stimulant | 0.1 0.004 CID_154699781 | CID_154699781 | |
| 0.113 | 0.054 | 0.113 | MAO B inhibitor | |||
| 0.125 | 0.066 | 0.125 | Acetylcholine antagonist | |||
| 0.091 | 0.032 | 0.091 | Adenosine A3 receptor antagonist | |||
| 0.113 | 0.055 | 0.113 | Alpha 2c adrenoreceptor antagonist | |||
| 0.081 | 0.023 | 0.081 | Alpha 2 adrenoreceptor agonist | |||
| 0.067 | 0.008 | 0.067 | AMPA 4 receptor antagonist | |||
| 0.073 | 0.015 | 0.073 | Dihydroorotate oxidase inhibitor | |||
| 0.076 | 0.019 | 0.076 | Calcium channel P-type blocker | |||
| 0.063 | 0.006 | 0.063 | Kainate receptor agonist | |||
| 0.062 | 0.005 | 0.062 | Free fatty acid receptor 1 antagonist | |||
| 0.062 | 0.005 | 0.062 | Leukotriene B4 receptor 1 antagonist | 0.044 0.009 CID_154699781 | ||
| 0.078 | 0.021 | 0.078 | Thromboxane antagonist | |||
| 0.067 | 0.01 | 0.067 | Sphingosine 1-phosphate receptor 3 agonist | |||
| 0.097 | 0.04 | 0.097 | Metalloproteinase-2 inhibitor | |||
| 0.067 | 0.011 | 0.067 | Oxytocin agonist | |||
| 0.08 | 0.025 | 0.08 | Exportin-1 inhibitor | |||
| 0.104 | 0.049 | 0.158 | Uric acid excretion stimulant | 0.158 0.021 CID_154699781 | CID_154699781 | |
| 0.067 | 0.013 | 0.067 | Fructose-1,6-bisphosphatase inhibitor | |||
| 0.061 | 0.007 | 0.061 | Lysophosphatidic acid 2 receptor antagonist | |||
| 0.093 | 0.039 | 0.093 | Somatostatin 1 agonist | |||
| 0.113 | 0.059 | 0.113 | Protein kinase C gamma inhibitor | |||
| 0.064 | 0.011 | 0.064 | Glutamate (mGluR group III) antagonist | |||
| 0.07 | 0.017 | 0.07 | Sphingosine 1-phosphate receptor 5 agonist | |||
| 0.057 | 0.004 | 0.057 | Estrogen-related receptor beta antagonist | |||
| 0.126 | 0.074 | 0.126 | Cyclooxygenase 1 inhibitor | |||
| 0.072 | 0.02 | 0.072 | Thromboxane A2 antagonist | |||
| 0.062 | 0.011 | 0.062 | Retinoid X alpha receptor agonist | |||
| 0.059 | 0.007 | 0.059 | Peroxisome proliferator-activated receptor alpha antagonist | |||
| 0.054 | 0.002 | 0.054 | Estrogen-related receptor gamma agonist | |||
| 0.151 | 0.1 | 0.151 | 3C-like protease (Human coronavirus) inhibitor | |||
| 0.069 | 0.018 | 0.069 | Thromboxane synthase inhibitor | |||
| 0.077 | 0.026 | 0.077 | Xanthine dehydrogenase inhibitor | |||
| 0.058 | 0.008 | 0.058 | Angiotensin AT1 receptor antagonist | |||
| 0.082 | 0.033 | 0.082 | S-adenosyl-L-methionine decarboxylase inhibitor | |||
| 0.136 | 0.086 | 0.136 | Cytidine deaminase inhibitor | |||
| 0.084 | 0.035 | 0.084 | Dopamine agonist | |||
| 0.052 | 0.003 | 0.052 | Estrogen-related receptor gamma antagonist | |||
| 0.06 | 0.012 | 0.06 | Kainate receptor 2 antagonist | |||
| 0.092 | 0.044 | 0.092 | Acetylcholine nicotinic antagonist | |||
| 0.056 | 0.008 | 0.056 | Heme oxygenase inhibitor | |||
| 0.059 | 0.011 | 0.059 | Fumarate hydratase inhibitor | 0.044 0.016 CID_154699781 | ||
| 0.056 | 0.008 | 0.056 | Delayed rectifier potassium channel blocker | |||
| 0.052 | 0.004 | 0.052 | Leukotriene B4 receptor 2 antagonist | 0.04 0.005 CID_154699781 | ||
| 0.066 | 0.019 | 0.066 | Dopamine D2 agonist | |||
| 0.052 | 0.005 | 0.052 | Liver X receptor alpha antagonist | |||
| 0.057 | 0.011 | 0.057 | GABA uptake inhibitor | |||
| 0.069 | 0.024 | 0.069 | Sigma receptor antagonist | |||
| 0.074 | 0.029 | 0.074 | Acetylcholine M3 receptor antagonist | |||
| 0.06 | 0.014 | 0.06 | AICAR transformylase inhibitor | |||
| 0.075 | 0.03 | 0.118 | Neuraminidase inhibitor | 0.118 0.01 CID_154699781 | CID_154699781 | |
| 0.089 | 0.044 | 0.089 | Caspase 7 inhibitor | |||
| 0.116 | 0.071 | 0.14 | Beta amyloid protein antagonist | 0.14 0.048 CID_154699781 | CID_154699781 | |
| 0.053 | 0.009 | 0.053 | Liver X receptor antagonist | |||
| 0.048 | 0.004 | 0.048 | Prostaglandin F2 alpha agonist | 0.023 0.014 CID_154699781 | ||
| 0.075 | 0.032 | 0.075 | NMDA receptor agonist | |||
| 0.067 | 0.024 | 0.079 | Lipocortins synthesis agonist | 0.079 0.014 CID_154699781 | CID_154699781 | |
| 0.074 | 0.031 | 0.134 | Neuraminidase (influenza) inhibitor | 0.134 0.009 CID_154699781 | CID_154699781 | |
| 0.147 | 0.104 | 0.147 | Tumour necrosis factor antagonist | |||
| 0.053 | 0.01 | 0.053 | Retinoid X receptor antagonist | |||
| 0.05 | 0.007 | 0.05 | Angiotensin II receptor antagonist | |||
| 0.047 | 0.005 | 0.047 | Calcium-independent phospholipase A2 inhibitor | 0.034 0.025 CID_154699781 | ||
| 0.064 | 0.022 | 0.064 | Opioid mu receptor agonist | |||
| 0.051 | 0.009 | 0.051 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | |||
| 0.054 | 0.011 | 0.054 | Peroxisome proliferator-activated receptor delta agonist | |||
| 0.057 | 0.015 | 0.057 | Urate transporter 1 inhibitor | |||
| 0.061 | 0.02 | 0.061 | CXC chemokine 1 receptor antagonist | |||
| 0.048 | 0.006 | 0.048 | Prostaglandin EP2 agonist | 0.025 0.014 CID_154699781 | ||
| 0.063 | 0.021 | 0.063 | Prolyl endopeptidase inhibitor | |||
| 0.068 | 0.027 | 0.068 | Botulinum neurotoxin type A inhibitor | |||
| 0.057 | 0.015 | 0.057 | Glutamate (mGluR4) antagonist | |||
| 0.073 | 0.032 | 0.073 | MDM2 inhibitor | |||
| 0.069 | 0.029 | 0.069 | Histone deacetylase SIRT3 inhibitor | |||
| 0.067 | 0.027 | 0.067 | Ornithine carbamoyltransferase inhibitor | |||
| 0.045 | 0.005 | 0.045 | Prostaglandin EP4 agonist | |||
| 0.049 | 0.009 | 0.049 | Vanilloid 3 antagonist | |||
| 0.07 | 0.03 | 0.07 | Transcription factor RelA inhibitor | |||
| 0.106 | 0.067 | 0.13 | Multidrug resistance-associated protein 1 inhibitor | 0.13 0.039 CID_154699781 | CID_154699781 | |
| 0.05 | 0.011 | 0.05 | Glutamate (mGluR8) agonist | |||
| 0.081 | 0.043 | 0.081 | Metalloproteinase-9 inhibitor | |||
| 0.077 | 0.039 | 0.077 | Matrix metalloproteinase inhibitor | |||
| 0.046 | 0.007 | 0.046 | Estradiol 17 beta-dehydrogenase 1 inhibitor | |||
| 0.066 | 0.029 | 0.077 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.077 0.022 CID_154699781 | CID_154699781 | |
| 0.077 | 0.04 | 0.077 | Phospholipase D inhibitor | |||
| 0.043 | 0.007 | 0.043 | Prostaglandin E2 agonist | |||
| 0.074 | 0.037 | 0.074 | HIV-1 integrase (3'-Processing) inhibitor | |||
| 0.041 | 0.004 | 0.041 | Acid ceramidase inhibitor | |||
| 0.059 | 0.022 | 0.059 | CD45 antagonist | |||
| 0.076 | 0.04 | 0.076 | Elastase 1 inhibitor | |||
| 0.054 | 0.017 | 0.054 | 5-Alpha-reductase inhibitor | |||
| 0.087 | 0.051 | 0.087 | Histamine H2 receptor antagonist | |||
| 0.068 | 0.033 | 0.068 | Phosphodiesterase 1B inhibitor | |||
| 0.059 | 0.024 | 0.238 | Heparanase inhibitor | 0.238 0.002 CID_154699781 | CID_154699781 | |
| 0.067 | 0.032 | 0.067 | Dopamine uptake inhibitor | |||
| 0.043 | 0.008 | 0.043 | Glutamate (mGluR3) agonist | |||
| 0.067 | 0.033 | 0.067 | Acetylcholine M5 receptor antagonist | |||
| 0.077 | 0.043 | 0.077 | Phosphodiesterase 5A inhibitor | |||
| 0.045 | 0.01 | 0.045 | Angiotensin AT2 receptor antagonist | |||
| 0.05 | 0.016 | 0.05 | Estradiol 17 beta-dehydrogenase 2 inhibitor | |||
| 0.044 | 0.01 | 0.044 | Retinoid X alpha receptor antagonist | |||
| 0.038 | 0.005 | 0.038 | Hedgehog signaling activator | |||
| 0.075 | 0.041 | 0.075 | Neuronal nicotinic receptor antagonist | |||
| 0.048 | 0.015 | 0.048 | Phosphoglycerate kinase inhibitor | |||
| 0.093 | 0.06 | 0.093 | Protein kinase C zeta inhibitor | |||
| 0.058 | 0.025 | 0.058 | Bombesin 2 receptor antagonist | |||
| 0.057 | 0.024 | 0.057 | Potassium channel (Inward rectifier) activator | |||
| 0.077 | 0.044 | 0.077 | Phosphodiesterase V inhibitor | |||
| 0.043 | 0.011 | 0.043 | Melatonin receptor 1A agonist | |||
| 0.054 | 0.022 | 0.054 | Nicotinic receptor alpha3 subunit antagonist | |||
| 0.075 | 0.043 | 0.075 | Prostaglandin-E synthase inhibitor | |||
| 0.074 | 0.042 | 0.074 | Alpha adrenoreceptor agonist | |||
| 0.047 | 0.015 | 0.078 | Squalene synthetase inhibitor | 0.078 0.008 CID_154699781 | CID_154699781 | |
| 0.048 | 0.017 | 0.083 | Arginase inhibitor | 0.083 0.005 CID_154699781 | CID_154699781 | |
| 0.042 | 0.011 | 0.058 | Uridine phosphorylase inhibitor | 0.058 0.006 CID_154699781 | CID_154699781 | |
| 0.061 | 0.03 | 0.061 | NMDA 2B receptor antagonist | |||
| 0.054 | 0.023 | 0.054 | Potassium channel (ATP-sensitive) activator | |||
| 0.049 | 0.019 | 0.049 | Plasmepsin II inhibitor | |||
| 0.049 | 0.019 | 0.049 | Dihydrofolate reductase inhibitor | |||
| 0.034 | 0.004 | 0.034 | Neuraminidase (Influenza B) inhibitor | 0.023 0.011 CID_154699781 | ||
| 0.057 | 0.027 | 0.112 | Glucose-6-phosphate translocase inhibitor | 0.112 0.005 CID_154699781 | CID_154699781 | |
| 0.06 | 0.031 | 0.06 | Alpha tubulin antagonist | |||
| 0.054 | 0.025 | 0.062 | Factor III inhibitor | 0.062 0.016 CID_154699781 | CID_154699781 | |
| 0.053 | 0.024 | 0.053 | Carbonic anhydrase VII inhibitor | |||
| 0.036 | 0.007 | 0.036 | Lysophosphatidic acid receptor 1 agonist | |||
| 0.06 | 0.031 | 0.06 | Matrix metalloproteinase 1 inhibitor | |||
| 0.064 | 0.036 | 0.064 | Prolactin release inhibitor | |||
| 0.05 | 0.021 | 0.05 | Kainate receptor antagonist | |||
| 0.071 | 0.043 | 0.071 | Sirtuin 1 inhibitor | |||
| 0.033 | 0.005 | 0.076 | Ileal bile acid transport inhibitor | 0.076 0.003 CID_154699781 | CID_154699781 | |
| 0.037 | 0.009 | 0.037 | CXC chemokine 2 receptor antagonist | |||
| 0.059 | 0.031 | 0.076 | Adenine nucleotide translocase inhibitor | 0.076 0.011 CID_154699781 | CID_154699781 | |
| 0.05 | 0.022 | 0.05 | Histamine H2 receptor agonist | |||
| 0.046 | 0.019 | 0.046 | Histone deacetylase 9 inhibitor | |||
| 0.04 | 0.012 | 0.04 | Methionyl aminopeptidase 1 inhibitor | |||
| 0.06 | 0.032 | 0.06 | Matrix metalloproteinase (membrane-type) inhibitor | |||
| 0.068 | 0.041 | 0.068 | Neutrophil collagenase inhibitor | |||
| 0.058 | 0.031 | 0.058 | Opioid agonist | |||
| 0.073 | 0.046 | 0.073 | Secretase beta inhibitor | |||
| 0.157 | 0.13 | 0.157 | Aryl hydrocarbon receptor agonist | |||
| 0.042 | 0.015 | 0.042 | Ceramide glucosyltransferase inhibitor | 0.042 0.015 CID_154699781 | ||
| 0.084 | 0.058 | 0.084 | mTOR complex 2 inhibitor | |||
| 0.031 | 0.004 | 0.031 | NMDA receptor phencyclidine site antagonist | |||
| 0.031 | 0.004 | 0.031 | Alpha 2b adrenoreceptor agonist | |||
| 0.116 | 0.09 | 0.116 | Toll-Like receptor antagonist | |||
| 0.042 | 0.016 | 0.042 | Sirtuin 2 inhibitor | |||
| 0.065 | 0.039 | 0.065 | HIV-1 integrase (Strand Transfer) inhibitor | |||
| 0.04 | 0.014 | 0.04 | Glucagon receptor antagonist | |||
| 0.048 | 0.023 | 0.06 | Guanylate cyclase inhibitor | 0.06 0.012 CID_154699781 | CID_154699781 | |
| 0.045 | 0.02 | 0.045 | Glutamate (mGluR group II) antagonist | |||
| 0.036 | 0.011 | 0.036 | Dopamine autoreceptor agonist | |||
| 0.045 | 0.02 | 0.045 | Histone deacetylase 7 inhibitor | |||
| 0.039 | 0.015 | 0.039 | Catechol O-methyltransferase inhibitor | |||
| 0.046 | 0.022 | 0.046 | Thymidine kinase inhibitor | |||
| 0.05 | 0.025 | 0.05 | Purinergic P2X4 antagonist | |||
| 0.049 | 0.025 | 0.07 | Neuraminidase (Influenza A) inhibitor | 0.07 0.007 CID_154699781 | CID_154699781 | |
| 0.065 | 0.041 | 0.065 | NMDA receptor glycine site agonist | |||
| 0.032 | 0.007 | 0.032 | Beta 1 adrenoreceptor agonist | |||
| 0.058 | 0.034 | 0.058 | Bombesin 3 receptor antagonist | |||
| 0.061 | 0.038 | 0.061 | Phosphodiesterase 1A inhibitor | |||
| 0.061 | 0.038 | 0.061 | Adenosine A1 receptor antagonist | |||
| 0.044 | 0.021 | 0.044 | Alpha 1d adrenoreceptor agonist | |||
| 0.063 | 0.041 | 0.063 | Prostaglandin F2 alpha antagonist | |||
| 0.027 | 0.005 | 0.027 | Retinoid X beta receptor antagonist | |||
| 0.042 | 0.021 | 0.042 | 5 Hydroxytryptamine 2B agonist | |||
| 0.029 | 0.008 | 0.029 | Fructose-1,6-bisphosphatase 1 inhibitor | |||
| 0.052 | 0.031 | 0.052 | Plasminogen activator inhibitor antagonist | |||
| 0.037 | 0.017 | 0.037 | Adenosine uptake inhibitor | 0.034 0.028 CID_154699781 | ||
| 0.039 | 0.019 | 0.039 | Glutamate (mGluR8) antagonist | 0.035 0.025 CID_154699781 | ||
| 0.061 | 0.041 | 0.061 | Cyclin D1 inhibitor | |||
| 0.033 | 0.013 | 0.033 | Purinergic P2Y15 antagonist | |||
| 0.034 | 0.015 | 0.034 | Sigma 2 receptor antagonist | |||
| 0.051 | 0.032 | 0.051 | Metalloproteinase-3 inhibitor | |||
| 0.029 | 0.01 | 0.029 | Complement factor 1s inhibitor | |||
| 0.073 | 0.054 | 0.073 | Potassium channel (Tandem pore domain) blocker | |||
| 0.093 | 0.075 | 0.093 | Glutamate (mGluR7) agonist | |||
| 0.035 | 0.017 | 0.035 | AMPA 1 receptor antagonist | |||
| 0.041 | 0.022 | 0.041 | Diamine oxidase inhibitor | |||
| 0.045 | 0.027 | 0.045 | Leukocyte elastase inhibitor | |||
| 0.056 | 0.038 | 0.056 | 5 Hydroxytryptamine 7 agonist | |||
| 0.031 | 0.013 | 0.031 | Prostaglandin H2 antagonist | |||
| 0.027 | 0.009 | 0.027 | Isoleucine-tRNA ligase inhibitor | 0.025 0.011 CID_154699781 | ||
| 0.024 | 0.007 | 0.024 | G-protein-coupled receptor 120 agonist | |||
| 0.035 | 0.017 | 0.035 | AMPA 3 receptor antagonist | |||
| 0.023 | 0.006 | 0.023 | Thyroid hormone alpha antagonist | |||
| 0.028 | 0.011 | 0.028 | Glutamate (mGluR1) agonist | |||
| 0.068 | 0.051 | 0.068 | Protein kinase C beta inhibitor | |||
| 0.027 | 0.01 | 0.033 | Dopamine D1 agonist | 0.033 0.007 CID_154699781 | CID_154699781 | |
| 0.076 | 0.059 | 0.076 | Chymotrypsin inhibitor | |||
| 0.041 | 0.025 | 0.041 | Membrane dipeptidase inhibitor | |||
| 0.023 | 0.007 | 0.037 | Antibiotic Anthracycline-like | 0.037 0.003 CID_154699781 | CID_154699781 | |
| 0.039 | 0.022 | 0.039 | 2,3-Oxidosqualene-lanosterol cyclase inhibitor | |||
| 0.02 | 0.004 | 0.02 | 1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor | |||
| 0.04 | 0.025 | 0.04 | CF transmembrane conductance regulator antagonist | |||
| 0.025 | 0.01 | 0.025 | Imidazoline I1 receptor antagonist | |||
| 0.097 | 0.081 | 0.097 | GABA receptor agonist | |||
| 0.034 | 0.019 | 0.034 | HCV NS5B polymerase inhibitor | |||
| 0.031 | 0.016 | 0.031 | Sigma 1 receptor antagonist | |||
| 0.03 | 0.015 | 0.03 | Prostaglandin EP4 antagonist | |||
| 0.06 | 0.045 | 0.06 | 5 Hydroxytryptamine 5A antagonist | |||
| 0.067 | 0.052 | 0.067 | HIV-1 integrase inhibitor | |||
| 0.018 | 0.004 | 0.018 | Thyroid hormone beta agonist | |||
| 0.023 | 0.009 | 0.023 | Thymidine kinase (Herpes simplex virus 2) inhibitor | |||
| 0.039 | 0.025 | 0.039 | Potassium channel Kv1.1 blocker | |||
| 0.043 | 0.03 | 0.043 | Dopamine D5 antagonist | |||
| 0.056 | 0.043 | 0.056 | Cathepsin L inhibitor | |||
| 0.106 | 0.093 | 0.106 | M17 leucyl aminopeptidase inhibitor | |||
| 0.02 | 0.007 | 0.029 | Telomerase stimulant | 0.029 0.003 CID_154699781 | CID_154699781 | |
| 0.083 | 0.07 | 0.139 | Falcipain inhibitor | 0.139 0.036 CID_154699781 | CID_154699781 | |
| 0.083 | 0.07 | 0.083 | Potassium channel activator | |||
| 0.029 | 0.016 | 0.029 | Lysine carboxypeptidase inhibitor | |||
| 0.029 | 0.016 | 0.029 | Baculoviral IAP repeat-containing protein 4 inhibitor | |||
| 0.043 | 0.03 | 0.043 | HIV-1 protease inhibitor | |||
| 0.055 | 0.043 | 0.055 | Acetyl-CoA transferase 2 inhibitor | |||
| 0.035 | 0.023 | 0.035 | RNA-directed RNA polymerase inhibitor | |||
| 0.032 | 0.02 | 0.032 | Cholesterol ester transfer protein antagonist | |||
| 0.036 | 0.024 | 0.036 | Opioid delta receptor agonist | |||
| 0.019 | 0.007 | 0.019 | Thromboxane A2 agonist | |||
| 0.068 | 0.056 | 0.068 | Calcium channel L-type blocker | |||
| 0.032 | 0.02 | 0.032 | Endothelial nitric-oxide synthase inhibitor | |||
| 0.02 | 0.009 | 0.02 | Alpha 2a adrenoreceptor agonist | |||
| 0.023 | 0.012 | 0.023 | Lysophosphatidic acid 1 receptor antagonist | |||
| 0.048 | 0.037 | 0.048 | Topoisomerase II beta inhibitor | |||
| 0.027 | 0.016 | 0.027 | Thymidine phosphorylase inhibitor | |||
| 0.022 | 0.011 | 0.022 | Toll-Like receptor 8 agonist | |||
| 0.024 | 0.013 | 0.024 | Glutamate (mGluR1a) agonist | |||
| 0.034 | 0.024 | 0.034 | Calcitonin receptor agonist | |||
| 0.033 | 0.023 | 0.033 | Melatonin agonist | |||
| 0.015 | 0.005 | 0.015 | Thromboxane agonist | |||
| 0.027 | 0.017 | 0.027 | Thymidine kinase (Herpes simplex virus 1) inhibitor | |||
| 0.03 | 0.02 | 0.03 | Thiazolidinedione | |||
| 0.023 | 0.013 | 0.023 | Angiotensin AT1A receptor antagonist | |||
| 0.043 | 0.034 | 0.043 | Dihydroorotase inhibitor | |||
| 0.03 | 0.021 | 0.03 | Peptide deformylase inhibitor | |||
| 0.079 | 0.071 | 0.135 | Falcipain 2 inhibitor | 0.135 0.035 CID_154699781 | CID_154699781 | |
| 0.027 | 0.019 | 0.027 | Motilin receptor antagonist | |||
| 0.018 | 0.009 | 0.018 | Vitamin D receptor agonist | 0.016 0.012 CID_154699781 | ||
| 0.016 | 0.008 | 0.016 | Angiotensin AT1B receptor antagonist | |||
| 0.019 | 0.011 | 0.019 | Aminopeptidase A inhibitor | |||
| 0.032 | 0.025 | 0.032 | Carboxypeptidase B inhibitor | |||
| 0.028 | 0.02 | 0.032 | 1,3-Beta-glucan synthase inhibitor | 0.032 0.01 CID_154699781 | CID_154699781 | |
| 0.051 | 0.044 | 0.051 | Angiotensin-converting enzyme inhibitor | |||
| 0.096 | 0.09 | 0.251 | Topoisomerase II inhibitor | 0.251 0.024 CID_154699781 | CID_154699781 | |
| 0.016 | 0.01 | 0.016 | Calcium-sensing receptor antagonist | |||
| 0.017 | 0.011 | 0.017 | Thyroid hormone alpha agonist | |||
| 0.016 | 0.01 | 0.016 | Purinergic P2Y1 agonist | |||
| 0.041 | 0.035 | 0.041 | Purinergic P2Y antagonist | |||
| 0.044 | 0.038 | 0.044 | Aldosterone antagonist | |||
| 0.013 | 0.007 | 0.013 | Glutamate (mGluR6) agonist | |||
| 0.014 | 0.009 | 0.014 | Lysophosphatidic acid receptor 3 agonist | |||
| 0.019 | 0.013 | 0.019 | Alpha 2c adrenoreceptor agonist | |||
| 0.018 | 0.012 | 0.018 | CXC chemokine 5 receptor antagonist | |||
| 0.055 | 0.049 | 0.055 | Cathepsin E inhibitor | |||
| 0.041 | 0.036 | 0.041 | Neurotensin receptor antagonist | |||
| 0.014 | 0.009 | 0.014 | Melatonin receptor 1A antagonist | |||
| 0.049 | 0.044 | 0.049 | Acetyl-CoA transferase inhibitor | |||
| 0.054 | 0.05 | 0.054 | Acetylcholine M2 receptor antagonist | |||
| 0.035 | 0.031 | 0.035 | TRPM8 blocker | |||
| 0.012 | 0.008 | 0.012 | Calcium-dependent phospholipase A2 inhibitor | |||
| 0.107 | 0.104 | 0.198 | DNA repair enzyme inhibitor | 0.198 0.009 CID_154699781 | CID_154699781 | |
| 0.018 | 0.015 | 0.018 | Methylmalonyl-CoA mutase inhibitor | |||
| 0.084 | 0.081 | 0.084 | Protease inhibitor | |||
| 0.066 | 0.063 | 0.066 | Alpha 2a adrenoreceptor antagonist | |||
| 0.015 | 0.013 | 0.015 | Adenosine A2 receptor agonist | |||
| 0.053 | 0.05 | 0.053 | 5 Hydroxytryptamine 5 antagonist | |||
| 0.01 | 0.008 | 0.01 | Imidazoline I2 receptor antagonist | |||
| 0.01 | 0.008 | 0.01 | Angiotensin AT2 receptor agonist | |||
| 0.036 | 0.034 | 0.036 | Histone deacetylase 8 inhibitor | |||
| 0.018 | 0.017 | 0.018 | Kainate receptor 1 antagonist | |||
| 0.03 | 0.028 | 0.03 | Melatonin 2 agonist | |||
| 0.014 | 0.012 | 0.014 | Adenosine A2a receptor agonist | |||
| 0.1 | 0.098 | 0.1 | Nav1.3 sodium channel blocker | |||
| 0.041 | 0.039 | 0.041 | Histamine H1 receptor agonist | |||
| 0.066 | 0.065 | 0.168 | Topoisomerase II alpha inhibitor | 0.168 0.02 CID_154699781 | CID_154699781 | |
| 0.057 | 0.056 | 0.057 | Heme oxygenase stimulant | |||
| 0.041 | 0.04 | 0.041 | Antimetabolite | |||
| 0.027 | 0.026 | 0.027 | Glutamate (mGluR2) antagonist | |||
| 0.053 | 0.056 | 0.416 | Selectin antagonist | 0.416 0.003 CID_154699781 | CID_154699781 | |
| 0.008 | 0.013 | 0.013 | Purinergic P2Y2 agonist | 0.013 0.005 CID_154699781 | CID_154699781 | |
| 0.094 | 0.102 | 0.381 | Cell adhesion inhibitor | 0.381 0.006 CID_154699781 | CID_154699781 | |
| 0.061 | 0.072 | 0.238 | Antineoplastic antibiotic | 0.238 0.016 CID_154699781 | CID_154699781 | |
| 0.039 | 0.053 | 0.08 | Aldose reductase inhibitor | 0.08 0.023 CID_154699781 | CID_154699781 | |
| 0.086 | 0.101 | 0.097 | Folate antagonist | 0.097 0.071 CID_154699781 | CID_154699781 | |
| 0.015 | 0.03 | 0.022 | Corticosteroid-like | 0.022 0.013 CID_154699781 | CID_154699781 | |
| 0.072 | 0.093 | 0.169 | Transcription factor NF kappa B stimulant | 0.169 0.013 CID_154699781 | CID_154699781 | |
| 0.116 | 0.139 | 0.152 | CC chemokine 6 receptor antagonist | 0.152 0.019 CID_154699781 | CID_154699781 | |
| 0.029 | 0.056 | 0.113 | Phosphorylase inhibitor | 0.113 0.011 CID_154699781 | CID_154699781 | |
| 0.029 | 0.057 | 0.067 | Carbonic anhydrase XII inhibitor | 0.067 0.03 CID_154699781 | CID_154699781 | |
| 0.047 | 0.076 | 0.063 | Transcription factor AP-1 inhibitor | 0.063 0.04 CID_154699781 | CID_154699781 | |
| 0.026 | 0.056 | 0.087 | Antibiotic Aminoglycoside-like | 0.087 0.004 CID_154699781 | CID_154699781 | |
| 0.034 | 0.066 | 0.129 | Protein 50S ribosomal subunit inhibitor | 0.129 0.008 CID_154699781 | CID_154699781 | |
| 0.021 | 0.052 | 0.039 | Toll-Like receptor 4 agonist | 0.039 0.005 CID_154699781 | CID_154699781 | |
| 0.015 | 0.049 | 0.067 | Protein 30S ribosomal subunit inhibitor | 0.067 0.005 CID_154699781 | CID_154699781 | |
| 0.068 | 0.105 | 0.231 | Topoisomerase I inhibitor | 0.231 0.02 CID_154699781 | CID_154699781 | |
| 0.068 | 0.112 | 0.13 | ATPase (Vacuolar H+) inhibitor | 0.13 0.014 CID_154699781 | CID_154699781 | |
| 0.003 | 0.053 | 0.016 | Antibiotic Macrolide-like | 0.016 0.009 CID_154699781 | CID_154699781 | |
| 0.012 | 0.073 | 0.033 | Motilin receptor agonist | 0.033 0.008 CID_154699781 | CID_154699781 | |
| 0.038 | 0.1 | 0.081 | Nitric oxide donor | 0.081 0.021 CID_154699781 | CID_154699781 | |
| 0.154 | 0.228 | 0.528 | Immunomodulator | 0.528 0.019 CID_154699781 | CID_154699781 | |
| 0.026 | 0.107 | 0.051 | Microtubule stabilization | 0.051 0.026 CID_154699781 | CID_154699781 | |
| 0.052 | 0.139 | 0.207 | Cell adhesion molecule inhibitor | 0.207 0.009 CID_154699781 | CID_154699781 | |
| 0.163 | 0.256 | 0.317 | Antiobesity | 0.317 0.105 CID_154699781 | CID_154699781 | |
| 0.04 | 0.218 | 0.127 | DNA intercalator | 0.127 0.054 CID_154699781 | CID_154699781 | |
| 0.056 | 0.247 | 0.095 | T cell inhibitor | 0.095 0.029 CID_154699781 | CID_154699781 | |
| 0.028 | 0.244 | 0.079 | Histone deacetylase stimulant | 0.079 0.045 CID_154699781 | CID_154699781 | |
| 0.028 | 0.244 | 0.079 | Histone deacetylase SIRT1 stimulant | 0.079 0.045 CID_154699781 | CID_154699781 | |
| 0.022 | 0.274 | 0.099 | Factor IXa inhibitor | 0.099 0.01 CID_154699781 | CID_154699781 | |
| 0.019 | 0.278 | 0.062 | DNA gyrase inhibitor | 0.062 0.046 CID_154699781 | CID_154699781 | |
| 0.042 | 0.343 | 0.268 | Anticoagulant | 0.268 0.035 CID_154699781 | CID_154699781 | |
| 0.036 | 0.575 | 0.213 | Angiogenesis inhibitor | 0.213 0.155 CID_154699781 | CID_154699781 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |